Market Place
Sourcing Support
Turn Therapeutics` AD Candidate Shows Promising Cytokine Inhibition
05 Aug 2024 //
PR NEWSWIRE
Turn`s Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
20 Jun 2024 //
BUSINESSWIRE
Turn Therapeutics Invites Investment For Wound, Eczema, Toenail Formulas
22 May 2024 //
BUSINESSWIRE
MIMEDX Announces Wound Surgical Product Pipeline Expansion Agreement with Turn
08 Dec 2022 //
GLOBENEWSWIRE
Turn Therapeutics Announces Trial Data for COVID-19 Early Intervention Candidate
25 Aug 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.